Nurix Therapeutics Inc (NRIX)

Stock price, financials, and technical signals for Nurix Therapeutics Inc (NRIX).

$10.51

-0.87

(-7.64%)

As of 04/03/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

NRIX Performance Snapshot


1-Week Chg

-16.25%

1-Month Chg

-25.93%

3-Month Chg

-46.68%

6-Month Chg

-51.50%

1-Year Chg

-27.96%

Year-To-Date Chg

-46.13%

Beta 1-Year

2.47

Beta 5-Year

2.20

Volatility (10-Day)

7.82%

NRIX Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-04-03

$10.51

-$0.87 (-7.64%)

$10.69

$10.91

$10.42

$10.61

834.00K ($8.77M)

2025-04-02

$11.38

$0.91 (8.69%)

$10.30

$11.44

$10.21

$11.01

1.23M ($13.99M)

2025-04-01

$10.47

-$1.41 (-11.87%)

$11.80

$11.89

$10.37

$10.91

2.40M ($25.11M)

2025-03-31

$11.88

-$0.27 (-2.22%)

$11.82

$12.03

$11.38

$11.76

1.35M ($16.09M)

2025-03-28

$12.15

-$0.40 (-3.19%)

$12.56

$12.72

$12

$12.29

623.32K ($7.57M)

2025-03-27

$12.55

-$0.18 (-1.41%)

$12.84

$13.10

$12.39

$12.68

577.85K ($7.25M)

2025-03-26

$12.73

$0.15 (1.19%)

$12.52

$12.78

$12.20

$12.57

830.58K ($10.57M)

2025-03-25

$12.58

-$0.76 (-5.7%)

$13.54

$13.54

$12.54

$12.89

847.24K ($10.66M)

2025-03-24

$13.34

$0.35 (2.69%)

$13.12

$13.57

$13.03

$13.31

976.10K ($13.02M)

2025-03-21

$12.99

-$0.88 (-6.34%)

$13.66

$13.67

$12.75

$13.14

2.29M ($29.72M)

NRIX Financials


Balance Sheet

(USD)

2024 Q4

Y/Y CHANGE


  • Cash and equivalents

    $110.90M

    99.72%

  • Total assets

    $669.34M

    88.23%

  • Total liabilities

    $142.35M

    -8.22%

  • Total investments

    $499.59M

    107.55%

  • Shareholders' equity

    $526.99M

    162.85%

  • Book value per share

    $6.73

    83.47%


Income Statement

(USD)

2024 Q4

Y/Y CHANGE


  • Revenue

    $13.28M

    -12.37%

  • Net income

    -$58.55M

    -39.55%

  • Operating expense

    $77.94M

    28.84%

  • Gross profit

    $13.28M

    -12.37%

  • EBITDA

    -$54.24M

    -41.99%

  • Earnings per share

    -$0.75

    2.60%


Cash Flow

(USD)

2024 Q4

Y/Y CHANGE


  • Net change in cash

    $10.95M

    -11.12%

  • Cash from operations

    -$48.75M

    -282.66%

  • Cash from investing

    -$140.82M

    -879.73%

  • Cash from financing

    $200.52M

    2864485.71%

  • Free cash flow

    -$50.86M

    -310.99%

  • Free cash flow per share

    -$0.65

    -247.17%


Metrics

(USD)

2024 Q4

Y/Y CHANGE


  • Market capitalization

    $1.57B

    419.13%

  • Enterprise value

    $1.49B

    460.39%

  • Shares outstanding

    70.84M

    46.04%

  • Profit margin

    -440.70%

    -59.21%

  • Gross margin

    100.00%

    0%

  • EBITDA margin

    -408.30%

    -62.02%


Dividends

(USD)

2024 Q4

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    6.46

    90.17%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.